ARTICLE | Clinical News
Ceprate SC: Started a Phase I trial
October 4, 1993 7:00 AM UTC
CellPro Inc. (CPRO) Product: Ceprate SC stem cell concentration system for separating stem cells with the CD34 marker Indication: Allogeneic bone marrow transplant Status: Started a Phase I trial in ...